Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.84% | 15.38% | -16.83% | -39.73% | -36.97% |
| Total Depreciation and Amortization | 92.26% | 73.17% | 76.46% | 61.26% | 29.53% |
| Total Amortization of Deferred Charges | -8.05% | -10.38% | -9.22% | -5.69% | -2.56% |
| Total Other Non-Cash Items | -65.52% | -14.59% | 38.89% | 86.71% | 17.48% |
| Change in Net Operating Assets | -748.44% | -155.63% | -454.68% | -2,427.51% | 38.49% |
| Cash from Operations | 32.58% | 7.77% | -17.55% | -36.72% | -42.78% |
| Capital Expenditure | -40.49% | -19.70% | 4.92% | -48.52% | -31.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 292.25% | 89.98% | 119.01% | 94.30% | 56.96% |
| Cash from Investing | 268.76% | 85.31% | 115.10% | 88.93% | 54.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 32.90% | 33.66% | -86.23% | -88.74% | -537.99% |
| Issuance of Common Stock | -87.48% | -90.24% | -21.54% | -19.91% | -28.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.42% | -91.41% | -30.17% | -28.85% | -17.28% |
| Foreign Exchange rate Adjustments | 2.93% | -180.98% | -195.56% | 171.23% | -147.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 148.78% | -2,070.84% | 192.97% | -161.36% | -393.68% |